Skip to main content
. Author manuscript; available in PMC: 2025 Jan 5.
Published in final edited form as: J Proteome Res. 2023 Dec 19;23(1):386–396. doi: 10.1021/acs.jproteome.3c00614

Table 3.

Comparison of Serum EVs from Healthy and Patient Samples from CD9-IC with a Standard Mixture of Cancer Cellsa

No Genes Accessions MixedStd Normal serum HCC serum Pan serum
1 CD9 P21926 6.3 - 5.1 -
2 CD81 P60033 6.2 - - -
3 ANXA2 P07355 5.9 3.4 4.5 3.2
4 LGALS3BP Q08380 5.4 4.9 - 5.0
5 SDCBP O000560 5.4 - 5.3 -
6 ITGB1 P05556 5.3 4.1 4.7 -
7 FN1 P02751 5.1 6.4 5.0 6.5
8 VIM P08670 5.1 - 4.2 -
9 PDCD6IP Q8WUM4 5.1 3.1 - -
10 ANXA1 P04083 5.1 - 4.5 -
11 ANXA4 P09525 5.1 4.7 - -
12 ANXA11 P50995 5.0 - 4.4 -
13 ANXA7 P20073 5.0 - 4.6 -
14 TFRC P02786 5.0 4.8 6.2 4.4
15 ANXA5 P08758 4.9 4.9 3.7 -
16 ANXA6 P08133 4.8 - - -
17 LYZ P61626 4.7 4.6 4.4 -
18 PF4 P02776 4.7 4.9 5.4 5.8
19 ANXA3 P12429 4.6 - - -
20 CD63 P08962 4.5 - 3.9 -
21 ALDH1A1 P00352 4.5 - 4.9 4.2
22 NT5E P21589 4.4 - - -
23 TSG101 Q99816 4.4 - - -
24 SDC1 P18827 4.3 - - -
25 MAPRE2 Q15555 4.3 - - -
26 ALDH1A3 P47895 4.2 - 5.9 4.8
27 CDH1 P12830 4.1 - - -
28 ALDH1L1 O75891 4.1 - - -
29 ALDH2 P05091 4.1 - - -
30 HGFAC Q04756 4.0 4.9 - 4.8
31 ALDH18A1 P54886 4.0 - - -
32 ALDH7A1 P49419 4.0 - 5.3 -
33 ALDH3A2 P51648 4.0 - 4.7 3.7
34 ALDH3A1 P30838 3.9 - - -
35 ALDH16A1 Q8IZ83 3.9 - - -
36 PARVB Q9HBI1 3.9 - - -
37 ALDH9A1 P49189 3.9 - - -
38 ALDH3B1 P43353 3.8 - - -
39 CDH2 P19022 3.7 - - -
40 PLEK P08567 3.6 - 5.1 -
41 CDH11 P55287 3.1 - - -
42 CDH5 P33151 - 4.5 - 4.4
a

A total of 42 EV markers were detected with varying levels of abundance. Abundance values were shown in Log10 scale and ranked from the highest to the lowest in mixed standard sample.